Innogenetics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LH | C | Laboratory Corporation of America Holdings | 0.56 | |
MYNZ | F | Mainz Biomed B.V. | -1.15 |
Related Industries: Diagnostics & Research
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IHF | D | iShares U.S. Health Care Providers ETF | 2.99 | |
NUMV | D | NuShares ESG Mid-Cap Value ETF | 1.32 | |
SAEF | C | Schwab Ariel ESG ETF | 1.3 | |
SCRD | C | Janus Henderson Sustainable Corp | 0.5 | |
GSIG | B | Goldman Sachs Access Investment Grade Corporate 1-5 Year Bond ETF | 0.43 |
Compare ETFs
Related Industries:
Diagnostics & Research
- Innogenetics
Innogenetics N.V. (now Fujirebio Europe N.V.) is an international in vitro diagnostics (IVD) company, with headquarters in Ghent, Belgium. The company develops and markets IVD testing solutions from specialized manual testing to fully automated routine testing that cover areas such as infectious diseases, oncology, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bone. The company was acquired in September 2010 by Japanese Fujirebio Inc., part of Miraca Holdings Inc., and changed name to Fujirebio Europe on October 1, 2013. The CEO of Fujirebio Europe N.V. is Christiaan De Wilde.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles